These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23433891)

  • 1. Squamous cell carcinogenesis and squamous cell carcinoma of the urinary bladder: a contemporary review with focus on nonbilharzial squamous cell carcinoma.
    Rausch S; Lotan Y; Youssef RF
    Urol Oncol; 2014 Jan; 32(1):32.e11-6. PubMed ID: 23433891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
    J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.
    Guo CC; Fine SW; Epstein JI
    Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD44s and CD44v6 in diagnosis and prognosis of human bladder cancer.
    Omran OM; Ata HS
    Ultrastruct Pathol; 2012 May; 36(3):145-52. PubMed ID: 22559040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schistosomiasis associated bladder carcinoma expression of cytokeratin.
    Essa MH; Mangoud AM; Aly MA; el-Adl M; Morsy TA
    J Egypt Soc Parasitol; 1990 Jun; 20(1):161-7. PubMed ID: 1692073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Squamous cell lesions of the urinary bladder].
    Rausch S; Gaisa N; Youssef RF; Lotan Y; Stenzl A; Kälble T
    Urologe A; 2014 Mar; 53(3):368, 370-4. PubMed ID: 24549798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Squamous cell carcinoma co-existing vesical leukoplakia--case study and its clinicopathological analysis of the pathogenesis].
    Yoshida K; Hattori T; Abe H; Akimoto M
    Hinyokika Kiyo; 1989 May; 35(5):885-9. PubMed ID: 2801383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The spectrum of histopathologic findings in vesical diverticulum: implications for pathogenesis and staging.
    Idrees MT; Alexander RE; Kum JB; Cheng L
    Hum Pathol; 2013 Jul; 44(7):1223-32. PubMed ID: 23375647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Your patient with carcinoma of the urinary bladder. Options for organ preservation].
    Zaak D
    MMW Fortschr Med; 2003 Jan; 145(5):28-32. PubMed ID: 12619205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome and patterns of recurrence of nonbilharzial pure squamous cell carcinoma of the bladder: a contemporary review of The University of Texas M D Anderson Cancer Center experience.
    Kassouf W; Spiess PE; Siefker-Radtke A; Swanson D; Grossman HB; Kamat AM; Munsell MF; Guo CC; Czerniak BA; Dinney CP
    Cancer; 2007 Aug; 110(4):764-9. PubMed ID: 17614317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Squamous cell carcinoma of the bilharzial and non-bilharzial urinary bladder: a review of etiological features, natural history, and management.
    El-Sebaie M; Zaghloul MS; Howard G; Mokhtar A
    Int J Clin Oncol; 2005 Feb; 10(1):20-5. PubMed ID: 15729596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinoma in a bladder diverticulum: presentation and treatment outcome.
    Golijanin D; Yossepowitch O; Beck SD; Sogani P; Dalbagni G
    J Urol; 2003 Nov; 170(5):1761-4. PubMed ID: 14532771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic significance of epidermoid metaplasia in urothelial carcinoma of the bladder].
    Vecchioli Scaldazza C; Morosetti D
    Arch Esp Urol; 1994 Sep; 47(7):671-3. PubMed ID: 7802470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
    Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
    J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Characterization of monoclonal antibody (BIU-H) directed against bladder cancer and its pathologic feature].
    Guo Y
    Zhonghua Yi Xue Za Zhi; 1992 Apr; 72(4):213-5, 254. PubMed ID: 1327448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of T2 muscle-invasive bladder cancer treated with neoadjuvant chemotherapy.
    Gilbert SM; Lee CT
    Nat Clin Pract Urol; 2006 Dec; 3(12):675-9. PubMed ID: 17149384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urothelial carcinoma of the bladder and the upper tract: disparate twins.
    Green DA; Rink M; Xylinas E; Matin SF; Stenzl A; Roupret M; Karakiewicz PI; Scherr DS; Shariat SF
    J Urol; 2013 Apr; 189(4):1214-21. PubMed ID: 23023150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histogenesis of nonurothelial carcinomas in the human and rat urinary bladder.
    Kunze E
    Exp Toxicol Pathol; 1998 Sep; 50(4-6):341-55. PubMed ID: 9784006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex steroids and gender differences in nonmuscle invasive bladder cancer.
    Lucca I; Fajkovic H; Klatte T
    Curr Opin Urol; 2014 Sep; 24(5):500-5. PubMed ID: 24978392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.